These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10585)

  • 1. Indications for long-term pharmacological treatment of schizophrenic syndromes.
    Perris C
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):149-58. PubMed ID: 10585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology.
    Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes.
    Jacobsson L; Von Knorring L; Mattsson B; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Acta Psychiatr Scand; 1976 Aug; 54(2):113-24. PubMed ID: 961459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in psychopathology in relation to EEG variables and visual averaged evoked responses (V.AER) in schizophrenic patients treated with penfluridol or thiothixene.
    d'Elia G; Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W
    Acta Psychiatr Scand; 1977 Apr; 55(4):309-18. PubMed ID: 855677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
    Altamura AC; Bobo WV; Meltzer HY
    Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms].
    Müller-Spahn F; Modell S; Thomma M
    Nervenarzt; 1992 Jul; 63(7):383-400. PubMed ID: 1354331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining symptom control: review of ziprasidone long-term efficacy data.
    Schooler NR
    J Clin Psychiatry; 2003; 64 Suppl 19():26-32. PubMed ID: 14728087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practical aspects of drug resistance in schizophrenia].
    Jarema M; Kucińska M
    Psychiatr Pol; 2000; 34(5):721-40. PubMed ID: 11202015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
    Wyatt RJ; Damiani LM; Henter ID
    Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 13. In conclusion: does antipsychotic treatment modify the long-term course of schizophrenic illness?
    Tandon R
    J Psychiatr Res; 1998; 32(3-4):251-3. PubMed ID: 9793878
    [No Abstract]   [Full Text] [Related]  

  • 14. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment strategies for schizophrenia.
    Lindenmayer JP; Khan A
    Expert Rev Neurother; 2004 Jul; 4(4):705-23. PubMed ID: 15853589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
    Iqbal MJ; Young MA; Charles J; Elgart B; Von Greiff H; Simpson GM
    J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizophrenic excitement and the role of lithium in its therapy (apropos of 2 recent cases)].
    Skurnik N; Shalev A; Munitz H; Tyano S
    Ann Med Psychol (Paris); 1985 Dec; 143(10):960-2. PubMed ID: 2873776
    [No Abstract]   [Full Text] [Related]  

  • 19. The outpatient clinic for patients under chronic lithium or neuroleptic treatment as a phase-IV research tool.
    Pietzcker A; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1984 Sep; 17(5):162-7. PubMed ID: 6149570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive medication in the maintenance treatment of schizophrenia and its conceptual implications.
    Siris SG
    Br J Psychiatry Suppl; 1993 Dec; (22):66-78. PubMed ID: 7906526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.